| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 103.939 | 88.009 | 89.979 | 91.740 | 115.749 | 90.723 | 117.557 | 94.975 | 127.063 | 125.209 |
| Total Income - EUR | 103.939 | 89.540 | 92.545 | 114.655 | 129.541 | 94.198 | 117.557 | 94.975 | 127.063 | 126.605 |
| Total Expenses - EUR | 96.802 | 83.767 | 85.626 | 123.787 | 121.904 | 79.729 | 97.423 | 83.425 | 107.453 | 142.845 |
| Gross Profit/Loss - EUR | 7.137 | 5.773 | 6.919 | -9.132 | 7.637 | 14.469 | 20.134 | 11.550 | 19.610 | -16.240 |
| Net Profit/Loss - EUR | 7.137 | 5.773 | 6.070 | -10.005 | 6.363 | 13.548 | 19.066 | 10.760 | 18.353 | -18.038 |
| Employees | 4 | 3 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Andomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.619 | 17.373 | 12.473 | 8.230 | 5.263 | 2.669 | 2.657 | 2.881 | 15.452 | 158.347 |
| Current Assets | 165.883 | 171.718 | 193.853 | 194.288 | 195.626 | 186.011 | 188.296 | 251.413 | 223.937 | 202.752 |
| Inventories | 144.112 | 150.197 | 177.228 | 181.864 | 174.157 | 170.676 | 167.353 | 178.546 | 150.279 | 115.481 |
| Receivables | 18.125 | 14.073 | 16.384 | 11.019 | 11.402 | 11.186 | 12.244 | 64.586 | 66.022 | 67.027 |
| Cash | 3.645 | 7.448 | 241 | 1.405 | 10.066 | 4.149 | 8.698 | 8.281 | 7.636 | 20.245 |
| Shareholders Funds | 22.186 | 27.732 | 33.333 | 22.716 | 28.640 | 41.645 | 59.788 | 70.733 | 89.074 | 70.538 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 170.018 | 161.359 | 172.992 | 179.802 | 172.249 | 147.035 | 131.165 | 183.638 | 150.344 | 290.572 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Andomed S.r.l.